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Abstract
Background: The influence of tobacco smoking on the immune system of HIV infected individuals is largely unknown. We
investigated the impact of tobacco smoking on immune activation, microbial translocation, immune exhaustion and T-cell
function in HIV infected individuals.
Method: HIV infected smokers and non-smokers (n = 25 each) with documented viral suppression on combination
antiretroviral therapy and HIV uninfected smokers and non-smokers (n = 15 each) were enrolled. Markers of immune
activation (CD38 and HLA-DR) and immune exhaustion (PD1, Tim3 and CTLA4) were analyzed in peripheral blood
mononuclear cells (PBMCs) by flow cytometry. Plasma markers of microbial translocation (soluble-CD14 - sCD14 and
lipopolysaccharide - LPS) were measured. Antigen specific functions of CD4+ and CD8+ T-cells were measured, by flow
cytometry, in PBMCs after 6 hours stimulation with Cytomegalovirus, Epstein-Barr virus and Influenza Virus (CEF) peptide
pool.
Results: Compared to non-smokers, smokers of HIV infected and uninfected groups showed significantly higher CD4+ and
CD8+ T-cell activation with increased frequencies of CD38+HLA-DR+ cells with a higher magnitude in HIV infected smokers.
Expressions of immune exhaustion markers (PD1, Tim3 and CTLA4) either alone or in combinations were significantly higher
in smokers, especially on CD4+ T-cells. Compared to HIV uninfected non-smokers, microbial translocation (sCD14 and LPS)
was higher in smokers of both groups and directly correlated with CD4+ and CD8+ T-cell activation. Antigen specific T-cell
function showed significantly lower cytokine response of CD4+ and CD8+ T-cells to CEF peptide-pool stimulation in smokers
of both HIV infected and uninfected groups.
Conclusions: Our results suggest that smoking and HIV infection independently influence T-cell immune activation and
function and together they present the worst immune profile. Since smoking is widespread among HIV infected individuals,
studies are warranted to further evaluate the cumulative effect of smoking on impairment of the immune system and
accelerated disease progression.
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Introduction
The prevalence of tobacco smoking among people living with
HIV is as high as 70% [1]. Although combination antiretroviral
therapy (cART) has resulted in enhanced immune reconstitution,
the extent of improvements are quite variable making the effects of
smoking on restoration of immune function difficult to elucidate.
Notably, evidence indicates that despite years of successful
treatment, immune activation (IA) and markers of inflammation
remain abnormally high during HIV infection [2]. These findings
are concerning given that IA has proven a better predictor of
disease progression than plasma viral load (VL) [3]. Recent studies
have highlighted the importance of gut microbial translocation
(MT) as a major contributing factor for IA [4–6]. Levels of soluble
CD14 (sCD14) and bacterial lipopolysaccharide (LPS), markers of
MT [6,7], remain high in HIV infected patients even after
prolonged cART with viral suppression. During the course of HIV
infection, T-cell functions such as proliferation and cytotoxic
potential appear to diminish gradually leading to an incremental
progression toward immune exhaustion (IE) [8]. Several markers
of IE like Programmed death-1 (PD1), T-cell Ig domain and
mucin domain-3 (Tim3), and Cytotoxic T-Lymphocyte Antigen-4
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(CTLA4) are negative regulators of IA and are preferentially up-
regulated on T-cells during HIV infection [9].
Cigarette smoke (CS) affects a wide range of immune functions
impacting innate and adaptive host immunity [10,11]. Clinical
and experimental studies have been inconsistent which might be
due to the nature of CS which has been shown to be both pro-
inflammatory and immunosuppressive [12,13]. Increased levels of
pro-inflammatory cytokines have been reported in chronic
smokers [14] as well as in HIV infected patients [15]. T-cells
from smokers exhibit difference in proliferation response to T-cell
mitogens and also in numbers, indicating defective T-cell
responses [10,16,17]. Proteomics and transcriptomic studies also
reveal that genes and proteins involved in immune function are
perturbed by CS [18,19]. Tobacco use has been known to
significantly increase the risk of pulmonary diseases in HIV
infected subjects along with many deleterious effects on antiret-
roviral treatment [20,21].
Although it is known that HIV infection [3] and smoking [22]
could impact T-cell activation, the effect of tobacco smoking on IA
and other associated immune defects like MT or IE is not well
understood in the context of HIV infection. We carried out this
pilot study to investigate the effect of tobacco smoking on HIV
infection. Here, we hypothesize that despite virologic suppression,
the combination of smoking and HIV infection leads to chronic
IA, thereby placing HIV-infected smokers at a higher risk of
infection compared to HIV infected non-smokers and HIV
uninfected age-matched controls. Our findings suggest that
smoking in HIV infected people can lead to increased IA, MT
and impairment of CD4+ and CD8+ T-cell functions that could
eventually influence disease progression and management.
Methods
Ethics Statement
The study was approved by the University of Miami Institu-
tional Review Board. Voluntary signed informed consent was
obtained from every participant prior to enrollment in the study.
Study Participants
The present study was conducted on four groups of participants:
HIV infected smokers (HIV+S, n= 25), HIV infected non-smokers
(HIV+NS, n= 25), HIV uninfected-smokers (HIVnegS, n = 15),
and HIV uninfected non-smokers (HIVnegNS, n= 15). The HIV
infected participants were referred to the study from local HIV
providers and community clinics as well as HIV testing centers. All
HIV infected participants in this study were on cART and
virologically suppressed (VL,50 copies/ml) at the time of
enrollment. Examination for each participant included the use of
standardized research questionnaires regarding tobacco, alcohol,
drug use, past and present medical history, physical examination
and laboratory testing. Our participant recruitment was based on
the National Health Interview Survey (NHIS) which defines
current smokers as individuals who have smoked at least 100
cigarettes and now smoke either every day or some days of the
week. Participants were enrolled if they were between 18–55 years
of age and a current tobacco smoker. Any individual with a
significant history of medical and immunological illness other than
HIV and tobacco usage like liver cirrhosis, myopathies, pregnan-
cy, malignancies, psychiatric conditions, malnutrition, cardiovas-
cular diseases and immunosuppressive conditions were excluded.
Drug abusers and daily hazardous alcohol abusers were also
excluded from the study. The demographic characteristics of the
four study groups are shown in Table 1.
Processing of Blood Samples
Blood was drawn by venipuncture and collected into heparin-
ized tubes for peripheral blood mononuclear cell (PBMC) isolation
and in EDTA tubes for plasma collection. Samples were processed
immediately after collection. Fresh PBMCs were isolated using
standard density gradient centrifugation method using Ficoll
Hypaque (GE Health Care Bio-sciences, PA). Cells at the interface
containing PBMCs were collected and washed twice in phosphate-
buffered saline (PBS; pH 7.2) and resuspended in RPMI 1640
(Cellgro, Mediatech, Inc. Manassas, VA) supplemented with 10%
heat-inactivated fetal bovine serum, 100 U/ml penicillin and
100 mg/ml streptomycin. PBMC were cryopreserved at 2140uC
and plasma was aliquoted and stored at 280uC until ready to be
assayed. Once thawed, the PBMCs were rested for 12 hours at
37uC, 5% CO2 and 100% humidity prior to using them for assays.
Cell recovery was .80% and viability was .95% in all instances.
Markers of Immune Activation and Exhaustion by
Multicolor Flow Cytometry
Thawed PBMCs (16106 cells/ml) were rested overnight and
stained with cell surface markers against CD3, CD4, CD8, CD38,
HLA-DR, PD1, Tim3 and CTLA4 (Biolegend, San Diego, CA) at
room temperature. Following incubation in the dark, cells were
washed, re-suspended in PBS with 1% paraformaldehyde and
acquired on FACSCanto Flow Cytometer (BD Bioscience, San
Jose, CA) after proper instrument settings, calibration, and
compensation [23,24] and analyzed using Diva software (version
5.0). A minimum of 200,000 events were analyzed and gating was
based on isotype controls. The CD4+ and CD8+ T-cells were
gated from CD3+ T-cells and analyzed for IA (HLA-DR and
CD38) and IE (PD1, CTLA4 and Tim 3).
Antigen Specific T-cell Function by Intracellular Staining
For the evaluation of intracellular cytokine production, PBMCs
(16106 cells/ml) were stimulated with 2 mg/ml Cytomegalovirus,
Epstein - Barr virus and Influenza Virus (CEF-Peptide Pool, NIH
AIDS Reagent Program). Staphylococcal Enterotoxin-B (SEB,
2 mg/ml) was included as a positive control and medium as
negative control. Cultures were incubated in the presence of
protein transport inhibitor, Brefeldin A (10 mg/mL; Sigma-
Aldrich) and Monensin (0.7 ml/ml; E-biosciences). For the
detection of degranulation, anti-CD107a was added at culture
initiation together with the aforementioned stimuli and incubated
at 37uC for 6 hours. After incubation, cells were washed and
stained with Abs for surface markers- CD3, CD4 and CD8. Cells
were then washed, fixed, permeabilized and stained intra-cellularly
with IL-2 and IFN-c mAbs, washed, re-suspended in PBS with 1%
paraformaldehyde and acquired on FACSCanto Flow Cytometer
and analyzed by Diva software as mentioned previously. Total
CD4+ and CD8+ T-cells were analyzed for the degranulation
marker, CD107a and cytokines (IL-2, IFN-c).
Markers of Microbial Translocation
Plasma levels of sCD14 and LPS were measured to detect
microbial translocation.
sCD14 Assay
Plasma levels of sCD14 were quantified [7,25] using human
sCD14 ELISA kit (R & D systems, Minneapolis, MN). Plasma
(10 ml) was diluted 400-fold and assayed in duplicate per
manufacturer’s recommendations. Results of sCD14 levels are
expressed in ng/ml.
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LPS Assay
Levels of LPS were measured in plasma by using the limulus
amebocyte lysate (LAL) chromogenic endpoint assay (Lonza
Group Ltd, Allendale, New Jersey, USA) according to manufac-
turer’s recommendations. Plasma (10 ml) was diluted 5-fold in
endotoxin-free water, and heat-inactivated at 8065uC for 15 min
to inactivate inhibitory plasma proteins before the assay. Following
subtraction of the background levels, results were calculated
relative to an Escherichia coli endotoxin standard provided with the
assay [4] and results of LPS are expressed in pg/mL.
Multiplex Cytokine Detection
Plasma levels of cytokines were measured using a customized
MILLIPLEX Cytokine Human Ultrasensitive magnetic bead
panel (EMD Millipore, Billerica, MA) following manufacturer’s
instructions. Briefly, plasma samples were thawed, vortexed and
centrifuged at 10,000 RPM for 5 min at 4uC prior to testing.
Undiluted plasma was incubated over night with a mixture of
beads specific for interleukins (IL-1b, IL-6, IL-8, IL-17) and tumor
necrosis factor alpha (TNFa) at 4uC with shaking. After washing,
the beads were incubated with biotinylated detection antibodies
for 1 hour at room temperature. Streptavidin-PE was then added
to the wells and allowed to incubate for 30 minutes at room
temperature. The beads were then washed and diluted with 150 ml
Sheath Fluid before acquisition on the MAGPIX instrument
(Luminex Corporation, Austin, TX). The mean fluorescent
intensity (MFI) data were analyzed with MILLIPLEX Analyst
Software V.3.5 (EMD Millipore). Cytokine concentrations were
determined based on standard curves and expressed in pg/ml.
Statistical Analysis
Statistical analysis began with a multivariate analysis of variance
to determine if there were significant group differences among the
dependent variables. If the Wilks Lambda statistic test indicated
that significant differences were present, analysis of covariance was
performed on each independent variable, using a general linear
model (GLM) approach. The first analysis of covariance model
included groups (HIV+S, HIV+NS, HIVnegS and HIVnegNS) and
covariates for a) number of alcoholic drinks per week and b) BMI.
A second analysis was run for smokers only that included group
(HIV+S and HIVnegS) with covariates for a) number of alcoholic
drinks per week, b) BMI and c) number of cigarettes per day. One
way ANOVA was used to perform five planned contrasts: HIV+S
vs. HIV+NS, HIVnegS vs. HIVnegNS, HIV+S vs. HIVnegS, HIV+S
vs. HIVnegNS and HIV+NS vs. HIVnegNS. Pearson correlation
was used to assess the associations among variables, and linear
regression was used to plot the data. Statistical test results with P
values of #0.05 were considered statistically significant. One way
ANOVA and Pearson correlation analyses were performed using
Prism 6.02 (GraphPad, La Jolla, CA) and multivariate analysis
using SAS 9.3 (SAS Institute, Inc., Cary, NC).
Results
Characteristics of Study Participants
The present study was conducted on four groups of participants:
HIV+S, n= 25, HIV+NS, n= 25, HIVnegS, n= 15, HIVnegNS,
n = 15. All HIV infected participants were receiving cART
according to the standard of care for more than 6 months at the
time of enrollment. Demographic characteristics of the study
groups are shown in Table 1. All HIV infected participants in this
study were virologically suppressed (VL,50 copies/ml). The white
blood count (WBC), lymphocyte%, CD3%, CD4% and CD8% of
the different study groups were not significantly different (Table 1).
In addition, absolute numbers of CD3+, CD4+ or CD8+ T-cells
were not significantly different between smokers and non-smokers
in the HIV infected group (data not shown). Unfortunately, WBC
and lymphocyte counts were unavailable for the HIV negative
smokers.
Immune Activation of CD4+ and CD8+ T-cells Increased
in Smokers
In adults with chronic HIV infection, markers of T-cell
activation are reported to be elevated even after antiretroviral
therapy [26]. We evaluated the phenotypic markers of T-cell
activation (CD38 and HLA-DR) in our study groups. As shown in
Fig. 1, frequencies of CD4+ and CD8+ T-cells expressing HLA-
DR either alone or in combination with CD38 were highest in the
HIV+S group compared to all other groups.
Table 1. Characteristics of the study participants.
Parameter HIV+S HIV+NS HIVnegS HIVnegNS
Number 25 25 15 15
Male 15 10 9 8
Age (years) 46 (24–52) 46 (38–52) 41 (22–53) 39 (27–51)
BMI (kg/m2) 30 (20–45) 33 (19–40) 28 (19–37) 33 (24–46)
Drinks/week 28 (0–112) 8 (02140) 10 (0–25) 1 (0–4)
Cigarettes/day 14 (2–30) 0 13 (1–28) 0
WBC (cells/ml) 5727 (2500–10800) 5963 (4000–11300) n.a 7125 (3700–9600)
Lymphocytes (%) 38 (25–50) 38 (23–53) n.a 37 (18–54)
CD3 (%) 79 (59–92) 77 (61–91) 70 (50–80) 74 (60–84)
CD4 (%) 31 (8–51) 27 (8–45) 44 (28–56) 44 (29–58)
CD8 (%) 43 (29–67) 46 (30–63) 25 (13–38) 33 (13–57)
HIV viral load (RNA copies/ml) ,50 ,50 n.a n.a
The table shows demographic characteristics of the study groups [mean (range)]. All HIV infected participants in this study were on cART and virologically suppressed
(VL,50 copies/ml) at the time of enrollment. Participants were enrolled if they were between 18–55 years of age and a current tobacco smoker based on the survey
questionnaire. Participants were excluded for any medical disorders and illicit drug use. n.a – not available.
doi:10.1371/journal.pone.0097698.t001
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Frequencies of HLA-DR+ and CD38+HLA-DR+ CD4+ T-cells
were significantly higher in HIVnegS compared to HIVnegNS
(P=0.04) which indicate the effect of smoking on CD4+ T-cell
activation in the general population. The differences in frequency
of CD4+ T-cell IA markers between the HIV+S and HIV+NS
were also significantly higher (P=0.03 and P=0.01) indicating the
synergistic effect of smoking on CD4 IA in HIV infected
individuals. Additionally, HIV+NS demonstrated significantly
higher frequencies of CD4+HLA-DR+ and CD4+CD38+HLA-
DR+ cells compared to HIVnegNS (P=0.001) indicative of the
effect of HIV infection on CD4+ T-cell activation (Fig. 1A and
1B). The median fluorescence intensity (MFI) of HLA-DR and
CD38 on CD4+ T-cells was also higher in HIV+S (data not shown)
suggesting per cell based increase in CD4 IA in HIV infected
smokers. The analysis of covariates for BMI and alcohol
consumption/week in all four study groups showed a negative
association between BMI and CD4 IA (HLA-DR+CD38+)
(P=0.03) but not with alcoholic drinks/week (Table 2). However,
number cigarettes/day did not show any association with markers
of CD4 IA in smoker groups. Similarly, the analysis of CD8+ T-
cells showed higher levels of IA as measured by increased
frequencies of CD8+HLA-DR+ and CD8+HLA-DR+CD38+ T-
cells in HIV+S compared to HIV+NS indicating the combined
effect of HIV and smoking on CD8+ T-cell activation (Fig. 1C and
1D). CD8+ T-cell IA was also evident in HIVnegS compared to
HIVnegNS suggesting the impact of smoking on T-cell activation
in the general population (Fig. 1D). Unlike CD4+ T-cell IA, CD8+
T-cell IA did not show any association with covariates BMI and
alcohol consumption/week or number of cigarettes/week in the
study groups (Table 2).
T-cells produce various cytokines upon activation; therefore we
evaluated the plasma levels of pro-inflammatory cytokines in the
study participants. Although differences between smoking and
non-smoking participants were not significant, increased levels of
circulating IL-1b, IL-6, IL-8, IL-17 and TNF-a were observed in
the smokers of both groups compared to the corresponding non-
smoking group (Table 3).
Higher Levels of Microbial Translocation in Smokers
Gut microbial translocation is known as an important contrib-
utor to IA in HIV infected patients [4,27]. We analyzed the
plasma levels of sCD14 and bacterial LPS, two reliable markers of
microbial translocation, in the study groups. Plasma sCD14 is an
indicator of LPS induced monocyte activation and has been
recently reported as an important correlate in HIV disease
progression and mortality [7]. Plasma sCD14 levels were
significantly higher in smokers of both HIV infected (P=0.03)
and uninfected groups (P=0.01) compared to their respective non-
smoker groups (Fig. 2A). In addition, we found significantly higher
levels of sCD14 in plasma from HIV+S compared to HIVnegS
(P=0.02) and in HIV+NS than HIVnegNS (P=0.02, Fig. 2A).
Importantly, correlation analysis showed that the sCD14 levels
correlated directly with both CD4+ (r=0.307; P=0.003) and
CD8+ T-cells IA (r=0.322; P=0.002) (Fig. 2B and 2C).
Figure 1. Higher cellular markers of T-cell activation in HIV infected and HIV uninfected smokers. Immune activation (CD38, HLA-DR)
markers were evaluated by flow cytometry in CD4+ and CD8+ T-cells of HIV+S (n = 25), HIV+NS (n = 25), HIVnegS (n = 15) and HIVnegNS (n = 15). (A–D)
Box plots show the frequency of activated T-cells: (A) CD4+HLA-DR+, (B) CD4+CD38+HLA-DR+, (C) CD8+HLA-DR+ and (D) CD8+CD38+HLA-DR+. Box
plots represent median with 25th and 75th percentile borders, error bars represent 10th and 90th percentile. The mean 6 standard error of mean
(SEM) for each group are given below the bar for that particular group.
doi:10.1371/journal.pone.0097698.g001
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Circulating LPS is an indicator of translocation of microbial
products from the gut into the bloodstream. Interestingly, plasma
LPS levels were significantly higher in HIVnegS compared to
HIVnegNS (P=0.009) which further demonstrates the effect of
smoking on microbial translocation regardless of HIV infection
(Fig. 2D). Significantly higher levels of plasma LPS were noted in
HIV+NS than HIVnegNS (P=0.002; Fig. 2D) which could be HIV
induced effect on gut permeability as described previously [4].
Additionally, plasma levels of LPS correlated directly with CD4+
(r=0.292; P=0.02) and CD8+ T-cell IA (r=0.302; P=0.01)
(Fig. 2E and 2F). However, we did not observe any association
between number cigarettes smoked/day, BMI or alcohol drinks/
week with plasma levels of sCD14 or LPS (Table 2).
Increased Levels of CD4+ T-cells Immune Exhaustion in
Smokers
Markers of IE were analyzed in order to understand the
relationship between IA and IE and its association with smoking in
HIV infected individuals. Compared to non-smokers, smokers of
both HIV infected and uninfected groups showed a significant
increase in the frequencies of CD4+ T-cells expressing PD1, Tim3
and CTLA4, either alone or in combination.
Frequencies of CD4+PD1+ cells were higher in HIV+S
compared to HIV+NS (P=0.0009). HIVnegS also showed higher
frequencies of CD4+PD1+ cells than HIVnegNS (P=0.0005)
indicating the influence of smoking on PD1 expression on CD4+
T-cells (Fig. 3A). In addition, CD4+PD1+ cells frequency was
higher in HIV+NS than HIVnegNS (P=0.004) showing the
independent effect of HIV infection on PD1 levels. Frequencies
of CD4+Tim3+ and CD4+CTLA4+ T-cells also showed a similar
pattern to CD4+PD1+ T-cells in all the groups (Fig. 3B and 3C)
indicting effect of tobacco on inducing multiple negative
regulatory molecules on CD4+ T-cells and subsequent increase
in immune exhaustion. Analysis of markers of immune exhaustion
on CD8+ T-cells showed an increase in the frequencies of CD8+
PD1+ cells in HIV+S when compared to HIV+NS (P=0.03) and
HIVnegS (P=0.001) (Fig. 3D). Also, significantly higher frequen-
cies of CD8+PD1+ T-cells were noticed in HIVnegS compared to
HIVnegNS (P=0.03) (Fig. 3D). In contrast to CD4+ T-cells,
frequencies of CD8+Tim3+ and CD8+CTLA4+ T-cells were not
significantly different between the groups (Fig. 3E and 3F).
In addition to the single expression pattern, we also analyzed
the combined expression of markers of immune exhaustion on
CD4+ and CD8+ T-cells. We analyzed the dual expression of
PD1+Tim3+, PD1+CTLA4+, and Tim3+CTLA4+ on CD4+ and
CD8+ T-cells. Our data showed that all these combinations were
significantly higher on CD4+ T-cells of HIV+S compared to
HIV+NS (P=0.001; P,0.0001 and P=0.005) and HIVnegNS
(P=0.001; P,0.0001and P=0.0001) (Fig. 3G, 3H and 3I)
indicating a significant impact of smoking on T-cell immune
exhaustion in HIV infection. The HIVnegS also demonstrated
higher expression of these combinations of inhibitory molecules
(PD1+Tim3+, PD1+CTLA4+, and Tim3+CTLA4+) on their
CD4+ T-cells suggesting a direct effect of smoking on CD4+ T-
cell immune exhaustion in otherwise healthy individuals (Fig. 3G,
3H and 3I). Frequencies of CD8+ T-cells with combinations of
PD1+CTLA4+ and Tim3+CTLA4+ cells did not show any
significant difference between HIV+S and HIV+NS or HIVnegS
which further confirm the selective effect of smoking on CD4+ T-
Table 2. Association of BMI, alcohol drinks/week and number of cigarettes/day with immune activation, microbial translocation
and immune exhaustion.
Parameter BMI Drinks/week Cigarettes/day
CD4+HLA-DR+CD38+ (%) 0.03* 0.66 0.64
CD8+HLA-DR+CD38+ (%) 0.31 0.1 0.5
Plasma LPS (pg/ml) 0.34 0.08 0.1
Plasma sCD14 (ng/ml) 0.18 0.95 0.63
CD4+PD1+ (%) 0.38 0.04* 0.19
CD8+ PD1+ (%) 0.55 0.08 0.99
We performed multivariate analysis to determine any significant group differences among the dependent variables. The first analysis model included groups (HIV+S,
HIV+NS, HIVnegS and HIVnegNS) and covariates for a) number of alcoholic drinks/week and b) BMI. A second analysis was performed for smokers only that included
groups (HIV+S and HIVnegS) with covariates for a) number of cigarettes/day, b) BMI and c) number of alcoholic drinks/week. The P values for the covariate regression
parameters for each specific marker are shown in the table. * - Negative association.
doi:10.1371/journal.pone.0097698.t002
Table 3. Plasma cytokine levels in the four groups of participants.
Cytokines (pg/ml) HIV+S (n =10) HIV+NS (n=10) P value HIVnegS (n=10) HIVnegNS (n =7) P value
IL-1b 3.12862.08 0.8660.33 0.40 3.6261.33 3.5761.66 0.98
IL-6 1.3460.55 0.4360.03 0.22 1.9160.76 1.1860.57 0.48
IL-8 10.0063.54 4.0961.58 0.48 9.0861.41 5.8161.75 0.16
IL-17 11.4869.7 1.3160.45 0.22 2.4761.96 0.5260.21 0.40
TNF-a 13.2263.51 10.3362.17 0.55 8.8161.18 6.3360.88 0.13
Circulating levels of cytokines were measured in the plasma of the four groups of participants using a customized MILLIPLEX Cytokine Human Ultrasensitive magnetic
bead panel (EMD Millipore). The differences between smoking and nonsmoking participants were not significant. But increased levels of circulating IL-1b, IL-6, IL-8, IL-17
and TNF-a were observed in the smokers of both groups compared to the corresponding non-smoking group.
doi:10.1371/journal.pone.0097698.t003
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cell exhaustion through the induction multiple inhibitory mole-
cules. Taken together, the frequencies of CD4+ and CD8+ T-cells
with increased expression of inhibitory molecules in combination
was highest in HIV+S compared with other groups (Fig. 3G to 3L).
Overall, our data suggest a more pronounced and selective effect
of smoking on exhaustion of CD4+ T-cells than CD8+ T-cells as
indicated by higher expression of multiple inhibitory molecules on
CD4+ T-cells.
Impaired Function of CD4+ and CD8+ T-cells in Smokers
In order to analyze the impact of smoking on antigen specific
and polyclonal T-cell function of HIV infected and uninfected
smokers, we stimulated PBMCs with CEF peptide pool and SEB.
Upon CEF stimulation, frequencies of IL-2 and CD107a positive
CD4+ T-cells were significantly lower in HIV+S (IL-2, P=0.03;
CD107a, P=0.02, Fig. 4A and 4C) compared to HIV+NS.
Additionally, frequencies of IFN-c and CD107a positive CD4+ T-
cells were significantly lower in HIVnegS (IFN-c, P=0.01;
CD107a, P= 0.02) compared to HIVnegNS (Fig. 4B and 4C).
The significant decrease in the production of CD107a in HIV+NS
compared to HIVnegNS (P=0.01) indicate the effect of HIV
infection on lowering the degranulation properties of antigen
specific memory of CD4+ T-cells. After polyclonal stimulation
with SEB, significantly lower IL-2 and CD107a expression was
observed in CD4+ T-cells of HIV infected smokers (Fig. 4D and
4F). These results indicate a generalized defect in antigen specific
and polyclonal CD4+ T-cell function in smokers and this could be
the result of higher levels immune exhaustion of CD4+ T-cells in
smokers.
When CD8+ T-cell function was analyzed, a significantly lower
production of antigen specific IL-2 and CD107a were observed in
CD8+ T-cells of HIV+S and HIVnegS indicating the independent
effect of smoking on CD8+ T-cell function (Fig. 5A, 5C). It is
important to note that the antigen specific degranulation property
of CD8+ T-cells was significantly affected by smoking even in HIV
uninfected participants. Additionally, after polyclonal stimulation,
significantly lower expression of CD107a was observed in HIV+S
than HIV+NS and of IL-2 in HIVnegS than HIVnegNS. Our data
indicate that like CD4+ T-cells, antigen specific CD8+ T-cell
function is also significantly affected by smoking. The IFN-c
production by CD8+ T-cells after antigen and polyclonal
stimulation was not affected by smoking in HIV infected or
uninfected participants (Fig. 5B and 5E).
Discussion
Persistent IA and inflammation associated with HIV infection
accelerates the process of immunosenescence, likely placing HIV
infected individuals at higher risk of developing infections. We
demonstrate that HIV infected individuals who smoke tobacco
products exhibit an increased state of immune activation and
exhaustion compared to HIV infected non-smokers and HIV
Figure 2. Elevated levels of microbial products in bloodstream of smokers are associated with immune activation. Plasma levels of
LPS (Limulus amebocyte lysate chromogenic endpoint assay) and sCD14 (ELISA) were measured in HIV+S (n = 25), HIV+NS (n = 25), HIVnegS (n = 15) and
HIVnegNS (n = 15). (A, B, C) Graphs depict the levels of sCD14 (ng/ml) in the 4 groups, HIV+S, HIV+NS, HIVnegS and HIVnegNS (A) and correlation of
sCD14 levels with CD4+CD38+HLA-DR+ (%) (B) and CD8+CD38+HLA-DR+ (%) (C); (D, E, F) Graphs shows the levels of LPS (pg/ml) in the 4 groups,
HIV+S, HIV+NS, HIVnegS and HIVnegNS (D) and correlation of LPS levels with CD4+CD38+HLA-DR+ (%) (E) and CD8+CD38+HLA-DR+ (%) (F). Box plots
represent median with 25th and 75th percentile borders, error bars represent 10th and 90th percentile. Correlation between the two variables is
indicated by the black continuous line in the correlation figures. The mean 6 SEM for each group are given below the bar for that particular group.
doi:10.1371/journal.pone.0097698.g002
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uninfected individuals. An increased level of sCD14 is indicative of
monocyte activation and T-cell activation is implied by the
increased surface expression of CD38 and HLA-DR. Higher T-
cell activation was accompanied by an increase in exhaustion
markers in HIV infected smokers and we also found increased
levels of MT that correlated with markers of immune activation.
These data represent the first comprehensive analysis of the
combined effect of HIV infection and smoking on the status of the
immune system in virologically controlled HIV infected smokers
who are on cART. Moreover, the multivariate analyses indicate
that being a member of the HIV positive smoking group was
significantly associated with higher frequencies of CD4+CD38+
HLA-DR+ (P = 0.0001), CD8+CD38+HLA-DR+ (P,0.0001) and
CD4+PD1+ (P,0.0001) T-cells and higher levels of LPS
(P = 0.002) and sCD14 (P,0.0001) compared to healthy controls
(HIVnegNS) (data not shown). These findings are significant
because they occur in a group of patients who are HIV infected
smokers and are at higher risk for infections. Although it is
reported that alcohol may work synergistically with HIV to
promote microbial translocation and immune activation [28], our
analysis did not show any significant effect of alcohol consumption
or number of cigarettes smoked/day on immune activation and
microbial translocation.
HIV infection results in chronic IA and overall immunological
dysfunction, and both of these closely associate with the
progression to AIDS [3,26,29]. Furthermore, even in those who
are successfully treated with HAART, persistent IA is associated
with increased morbidity and mortality [30–32]. Microbial
translocation is one of the most important [4,5] factors implicated
in triggering IA in HIV-infected patients. The presence of
bacteria-derived products in the bloodstream [4,27] is sensed by
toll-like receptors [33] that are responsible for inducing the
production of inflammatory mediators that contribute to systemic
IA. Microbial translocation has been associated with severity of
HIV infection [34] and elevated levels of LPS in the plasma of
HIV infected ART-treated individuals have been used as an
indicator of long-lasting damage to the gut [27]. Even though VL
of HIV+S and HIV+NS were controlled, smokers showed
significantly higher CD4+ and CD8+ T-cell activation compared
to non-smokers. HIV infected smokers also demonstrated
Figure 3. Higher levels of immune exhaustion markers in smokers compared to non-smokers. T-cell exhaustion markers (PD1, Tim3, and
CTLA4) were evaluated by flow cytometry in CD4+ and CD8+ T-cells of HIV+S (n = 25), HIV+NS (n = 25), HIVnegS (n = 15) and HIVnegNS (n = 15). (A, B, C)
frequency of exhausted CD4+ T-cells: CD4+PD1+ (A), CD4+Tim3+ (B), CD4+CTLA4+ (C) and (D, E, F) frequency of exhausted CD8+ T-cells: CD8+PD1+
(D), CD8+Tim3+ (E) and CD8+CTLA4+ (F). (G–L) Pie chart shows the comparison of frequencies of dual positive markers in CD4+ and CD8+ T-cells of
HIV+S, HIV+NS, HIVnegS and HIVnegNS: CD4+PD1+Tim3+ (G); CD4+PD1+CTLA4+ (H); CD4+Tim3+CTLA4+ (I); CD8+PD1+Tim3+ (J); CD8+PD1+CTLA4+ (K)
and CD8+Tim3+CTLA4+ (L). Box plots represent median with 25th and 75th percentile borders, error bars represent 10th and 90th percentile. The
mean 6 SEM for each group are given below the bar for that particular group.
doi:10.1371/journal.pone.0097698.g003
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increased levels of pro-inflammatory cytokines compared to rest of
the groups [14,15]. It is reported that under well monitored HIV
care, HIV+S lose more life-years to smoking than to HIV [35]. An
interesting observation was the higher CD4+ T-cell immune
activation in HIVnegS than HIVnegNS indicating a direct
association of smoking in the activation of CD4+ T-cells which
could affect overall immune response. It is reported that levels of
lipopolysaccharide-binding protein and sCD14 in the bronchoal-
veolar lavage of smokers are significantly higher than non-smokers
[36]. Our analysis of gut MT showed higher levels of sCD14 and
LPS in smokers and it correlated with CD4+ and CD8+ immune
activation supporting the notion that MT might have a role in
inducing IA [4,26]. Increases in sCD14 levels in HIVnegS indicate
the direct association of smoking with sCD14 levels. It is possible
that gut permeability is damaged in smokers compared to non-
smokers which might lead to MT and subsequent systemic IA.
Our results indicate that MT might be the main factor behind IA
in smokers and persistent IA is associated with accelerated disease
progression in HIV infected individuals [37].
Our data indicate that there is selective up-regulation of
multiple inhibitory molecules on CD4+ T-cells which might be
significant contributor to the IE state and that CD4+ and CD8+
T-cells show different patterns of expression of inhibitory
molecules in smokers [38]. In agreement with previous reports,
we found increased expression of PD1 on both CD4+ and CD8+
T-cells of HIV infected subjects [39]. Additionally, significantly
higher PD1 expression was observed in HIV+S than HIVnegS
which indicates a synergistic effect of smoking with HIV on IE
status of HIV infected individuals. Frequencies of other IE
markers (Tim3 and CTLA4) along with combined IE marker
frequencies (PD1 and Tim3, PD1 and CTLA4 and Tim3 and
CTLA4) were also significantly higher in CD4+ T-cells of smokers
of both HIV infected and uninfected groups. As we enrolled
patients with undetectable VL in both smoking and non-smoking
groups of HIV patients, viremia might not be the reason behind
the observed difference in IE. The T-cells from smokers were more
exhausted than non-smokers indicating that mechanisms other
than viral persistence might be the reason for development of IE
during HIV infection.
Although smoking independently enhanced T-cell activation in
HIVnegS, data on the effects of smoking on immune function in
HIV infected individuals are limited. Since increased expression of
inhibitory molecules was observed on CD4+ and CD8+ T-cells of
HIV+S and HIVnegS, we further analyzed the effect of smoking on
the functionality of T-cells. We found significant differences in the
IL-2 and CD107a production to recall responses and polyclonal
Figure 4. Decreased frequency of IL-2 and CD107a producing CD4+ T-cells in smokers compared to non-smokers. CD4+ T-cell function
was analyzed by intracellular staining for cytokines IL-2, IFN-c and degranulation marker CD107a using flow cytometry in the PBMCs of all four groups
of participants [HIV+S (n = 25), HIV+NS (n = 25), HIVnegS (n = 15) and HIVnegNS (n = 15)] after 6hrs of stimulation with CEF and SEB in the presence of
Brefeldin A and Monensin. (A, B, C) Box plots show the frequencies of CD4+ T-cells which produced IL-2 (A), IFN-c (B) and CD107a (C) after stimulation
with CEF in the four groups of participants. (D, E, F) Box plots show the frequencies of CD4+ T-cells which produced IL-2 (D), IFN-c (E) and CD107a (F)
after stimulation with SEB in the four groups of participants. Box plots represent median with 25th and 75th percentile borders, error bars represent
10th and 90th percentile.
doi:10.1371/journal.pone.0097698.g004
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stimulation in both CD4+ and CD8+ T-cells of smokers
irrespective of their HIV status. These findings need further
investigation as the reduced T-cell function in smokers will have
long lasting effects on overall immune response to vaccinations or
other infections. Reduced IL-2 production by CD4+ T-cells has
been associated with decreased antibody responses to influenza
vaccination in older people [40,41]. The quality of CD4+ T-cells
in smokers has been significantly affected and this defect in their
immune function could explain why smokers develop serious
complications during an infectious disease. Cigarette smoking is
reported as an independent risk factor for invasive pneumococcal
disease in immune-competent adults and this risk is positively
correlated with smoking pack-years [42], which could be a result
of smoking-associated reductions in T-cell function. In our study,
specific T-cell functional capacity was reduced in smokers
regardless of their HIV status and this is in agreement with
previous proteomic and transcriptomic studies which reported that
proteins and genes involved in immune-function are altered in
smokers [18,19]. HIV infected smokers are at increased risk of
incidence of bronchitis [43] and bacterial pneumonia [44,45] due
to higher immune defects. Limitations of the study include the
small sample size and absence of absolute counts for the HIV
uninfected smokers.
As a pilot, however, this study demonstrates that HIV-infected
ART-treated smokers who are virologically suppressed have
higher levels of immune activation and exhaustion than HIV-
infected age matched non-smokers and HIV uninfected controls.
In conclusion, to the best of our knowledge, this is the first report
on the effect of smoking on different immune markers in smokers,
especially in an HIV infected cohort. Our study also provides
evidence that smoking is associated with compromised immune
cell functionality. Still there are many questions which need to be
answered including whether IA could lead to opportunistic
infections, whether there is accelerated replication of the virus,
or whether there is increased damage to the immune system of
smokers. Future studies should be focused on understanding the
mechanisms of IA/IE and its impact on disease progression and its
correlation with clinical outcomes in HIV-infected smokers. As
recently suggested, viral persistence is facilitated by IA, and
strategies to contain IA including control of MT need to be further
explored in these patients.
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